OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Video overview of cDNA clone offering
Video brochure for cDNA clone
Related Products

Over 1000 citations of OriGene cDNA clones
A murine Zic3 transcript with a premature termination codon evades nonsense-mediated decay during axis formation Dis. Model. Mech., May 2013; 6: 755 - 767. [ZIC5 ]

Brain and muscle Arnt-like 1 is a key regulator of myogenesis J. Cell Sci., May 2013; 126: 2213 - 2224. [MyoD1]

CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer Cancer Res., May 2013; 73: 2795 - 2805. [CHD1]

Deregulation of Wnt/ß-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors Carcinogenesis, May 2013; 34: 953 - 961. [WIF1]

View All Citations >>

 

HomeAll Cancer Mutant ClonesPIK3C2G Mutants

Description of the mutations of PIK3C2G (NM_004570) Mutants

Keys for Mutation Description

A.A. substitution
Truncation
NT deletion
NT insertion
R280G: Arg at aa-position 280 mutated to Gly
R342X: R at aa-position 342 mutated to a stop codon and caused truncation of the protein
N268_D2: The deletion starts at nt#268. Two bases (including nt268) are deleted
N478-I6: The insertion starts after nt#478. Six bases are inserted

 

SKUMutation DescriptionAffected Codon#Affected NT#DescriptionEffect
RC402758 P146L146437C>TDibees, ype 2, ssoiion wih

 

bar
Inc 5000 Healthcare Company Copyright © 2013 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title